Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Micell Technologies Inc Company Overview 4
Micell Technologies Inc Company Snapshot 4
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Micell Technologies Inc – Pipeline Analysis Overview 7
Micell Technologies Inc – Key Facts 7
Micell Technologies Inc – Major Products and Services 8
Micell Technologies Inc Pipeline Products by Development Stage 9
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 11
Micell Technologies Inc Pipeline Products Overview 13
Bioresorbable Scaffold (BRS) 13
Bioresorbable Scaffold (BRS) Product Overview 13
Drug-Coated Balloon 14
Drug-Coated Balloon Product Overview 14
MiStent SES 15
MiStent SES Product Overview 15
MiStent SES Clinical Trial 16
Peripheral Drug-Eluting Stent 18
Peripheral Drug-Eluting Stent Product Overview 18
Micell Technologies Inc – Key Competitors 19
Micell Technologies Inc – Key Employees 20
Micell Technologies Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Micell Technologies Inc, Recent Developments 22
Dec 06, 2017: The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent Performance in All-Comers Randomized Trial; MiStent Achieved Primary Endpoint vs Xience 22
May 16, 2017: Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience 23
Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 24
Oct 31, 2016: Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 24
Mar 22, 2016: Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience 25
Feb 25, 2016: Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES and Market Standard Xience V Coronary Stent 26
Dec 09, 2015: Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial against Xience 28
Oct 13, 2015: Positive Four-Year Clinical Data from Micell Technologies’ MiStent SES Presented at TCT 2015 28
Aug 20, 2015: Micell Technologies Announces Surgical Technologies Approved as MiStent SES Commercial Manufacturer for CE Mark Countries 29
Jul 22, 2015: Micell Begins MiStent SES Trial In China 30
Appendix 31
Methodology 31
About GlobalData 33
Contact Us 33
Disclaimer 34
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Micell Technologies Inc Pipeline Products by Equipment Type 5
Micell Technologies Inc Pipeline Products by Indication 6
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 6
Micell Technologies Inc, Key Facts 7
Micell Technologies Inc, Major Products and Services 8
Micell Technologies Inc Number of Pipeline Products by Development Stage 9
Micell Technologies Inc Pipeline Products Summary by Development Stage 10
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 11
Micell Technologies Inc Ongoing Clinical Trials Summary 12
Bioresorbable Scaffold (BRS) - Product Status 13
Bioresorbable Scaffold (BRS) - Product Description 13
Drug-Coated Balloon - Product Status 14
Drug-Coated Balloon - Product Description 14
MiStent SES - Product Status 15
MiStent SES - Product Description 15
MiStent SES - A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent System) in the Treatment of Patients with Coronary Heart Disease 16
MiStent SES - MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) Optical Coherence Tomography (OCT) 16
MiStent SES - Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries 16
MiStent SES - Multicenter Randomized Study of the Mistent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries 17
Peripheral Drug-Eluting Stent - Product Status 18
Peripheral Drug-Eluting Stent - Product Description 18
Micell Technologies Inc, Key Employees 20
Glossary 32